Sjögren’s disease is a chronic autoimmune disorder primarily affecting the salivary and lacrimal glands, leading to pronounced dryness of the mucous membranes. The condition may occur as a primary disease or in association with other rheumatic disorders, including rheumatoid arthritis and systemic lupus erythematosus.
When is treatment required?
Treatment is required in cases of persistent dryness of the mouth and eyes, a sensation of “grit” in the eyes, burning, difficulty swallowing, and recurrent inflammation of the salivary glands. The disease may also be accompanied by fatigue, joint and muscle pain, and involvement of the skin, lungs, kidneys, and nervous system. Early therapy helps slow disease progression and prevent systemic complications.
How is Sjögren’s disease treated?
Treatment of Sjögren’s disease is aimed at controlling autoimmune inflammation and relieving symptoms. Anti-inflammatory and immunomodulatory medications are used; when indicated, glucocorticosteroids and disease-modifying therapy are prescribed. Agents for moisturizing mucous membranes as well as medications that stimulate salivary and tear secretion are widely used. Regular follow-up with a rheumatologist and monitoring of internal organ involvement play a key role.
Treatment for Sjögren’s disease is available in leading clinics in Belarus, where a comprehensive approach to autoimmune disorders is applied in accordance with international clinical guidelines.
